Press Releases - Lifestyle Escoffier Announces Partnership With Les Roches to Expand International Academic Footprint August 27, 2026
Press Releases - Lifestyle Holland America Line Opens 2028 Alaska Season with Rare Voyages and New Ways to Explore the Great Land August 27, 2026
Press Releases - Food & Drink Dave’s Killer Bread reveals new consumer insights for Organic Month August 27, 2026
Press Releases Percent Strengthens Executive Leadership as Private Credit Platform Scales Asset Management Business August 27, 2026
Press Releases CGMA OPENS NEW CHAPTER IN 102-YEAR HISTORY WITH FIRST INDEPENDENTLY ELECTED BOARD PRESIDENT August 27, 2026
Press Releases Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit August 27, 2026
Press Releases Porter Capital Closes $10 Million Facility for Family-Owned Seafood Processor August 27, 2026
Press Releases - Lifestyle The World’s Gold Mines Are Draining Faster Than New Ones Get Built; The Market Is Rewarding Whoever Can Pour First August 27, 2026
Press Releases - Lifestyle Maven Members with High-Risk Pregnancies See 32% Fewer NICU Admissions August 27, 2026
Press Releases - Lifestyle USTA Coaching Tops 17,000 Community Members in First Year as Tennis Boom Drives Demand for More Coaches August 27, 2026
Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer 4 months ago